ヘカバイオ株式会社

HekaBio is an ecosystem for a healthcare development platform that offers oncology and ophthalmology research.

Based based in Tokyo, Japan, ヘカバイオ株式会社 works in medtech, founded in 2017.

Profile

私たちは、オンコロジー、カーディオロジー、眼科領域、 中枢神経系分野を中心に、投資、開発、商業化を実現する 日本発のプラットフォームです

Within the medtech space, the company focuses on its core offering rather than a broad product line.

The business is associated with Tokyo, Japan.

It is recorded at the Series_B stage.

Its team size is recorded as c_00011_00050 employees.

Public records show total funding of about $21.9M.

Website: www.heka.bio/home-jp